Soranib 200 Mg Tablet
1000.0 INR/Bottle
Product Details:
- Origin of Medicine India
- Salt Composition Sorafenib Tosylate 200 mg
- Dosage Form Solid, Oral tablet
- Indication Treatment of liver cancer, kidney cancer, and thyroid cancer
- Pacakaging (Quantity Per Box) 30 tablets per bottle
- Drug Type General Medicines
- Ingredients Sorafenib Tosylate
- Click to View more
X
Soranib 200 Mg Tablet Price And Quantity
- 1 Bottle
- 1000.0 INR/Bottle
- Cipla Pharmaceuticals
- 24 months from manufacturing date
- Present on label
- Yellow
- Room temperature shipping
- Oral
- Not recommended for pregnant or breastfeeding women, or patients with severe liver impairment
- Present on packaging
- Possible side effects include diarrhea, fatigue, rash, hypertension, and hand-foot skin reactions
- Yes
- Antineoplastic agents
- Oval
- DCGI approved
Soranib 200 Mg Tablet Product Specifications
- General Medicines
- India
- Solid, Oral tablet
- Patients diagnosed with advanced renal cell carcinoma, hepatocellular carcinoma, and thyroid carcinoma
- Anti-cancer medication (tyrosine kinase inhibitor)
- Sorafenib Tosylate 200 mg
- Treatment of liver cancer, kidney cancer, and thyroid cancer
- Store below 30C, protect from moisture and light
- Adults
- 200 mg
- Tablets
- 30 tablets per bottle
- As prescribed by the oncologist
- Sorafenib Tosylate
- Cipla Pharmaceuticals
- 24 months from manufacturing date
- Present on label
- Yellow
- Room temperature shipping
- Oral
- Not recommended for pregnant or breastfeeding women, or patients with severe liver impairment
- Present on packaging
- Possible side effects include diarrhea, fatigue, rash, hypertension, and hand-foot skin reactions
- Yes
- Antineoplastic agents
- Oval
- DCGI approved
Soranib 200 Mg Tablet Trade Information
- 100 Bottle Per Month
- 7 Days
Product Description
Soranib Tablet should be taken on an empty stomach, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Fatigue, nausea, loss of appetite, hair loss and diarrhea are some common side effects of this medicine. It might cause high blood pressure, so the doctor may ask you for a regular check-up of blood pressure. You must inform your doctor if you notice severe skin reaction such as skin rash, or any pain, swelling, and redness of your hands and feet.
Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or high blood pressure. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Comprehensive Cancer Treatment
Soranib 200 Mg Tablet offers a targeted approach in managing advanced cancers such as liver, kidney, and thyroid carcinoma. Its active ingredient, Sorafenib Tosylate, inhibits cancer cell growth, providing patients with a trusted and clinically approved treatment option by Cipla Pharmaceuticals.
Convenient Oral Administration
With an easy-to-swallow oval-shaped yellow tablet design, Soranib is administered orally. This format allows patients to take their medication at home as per their oncologist's guidance, integrating seamlessly into daily routines and ensuring consistent therapeutic efficacy.
Safe Storage and Quality Assurance
Each bottle contains 30 tablets and features both batch numbers and barcodes for secure tracking. The tablets require storage below 30C, protected from moisture and light, maintaining potency and ensuring safety throughout the 24-month shelf life.
FAQ's of Soranib 200 Mg Tablet:
Q: How should I take Soranib 200 Mg Tablet?
A: Soranib 200 Mg Tablet should be taken orally, exactly as prescribed by your oncologist. Do not crush or break the tablet, and take it with or without food as instructed by your doctor.Q: What are the benefits of using Soranib 200 Mg Tablet?
A: Soranib is an approved anti-cancer therapy specifically designed to manage advanced cases of kidney, liver, and thyroid cancers. It works by inhibiting tumor growth and spreading, offering improved disease control.Q: When should I avoid taking Soranib 200 Mg Tablet?
A: Do not use this medication if you are pregnant, breastfeeding, or have severe liver impairment. Always inform your healthcare provider of any existing health conditions before starting this treatment.Q: Where can I find the batch number and barcode for Soranib?
A: The batch number is present on the label, and the barcode can be found on the packaging of the bottle, ensuring authenticity and traceability of the product.Q: What are the possible side effects of Soranib 200 Mg Tablet?
A: Some common side effects may include diarrhea, rash, fatigue, hypertension, and hand-foot skin reactions. Consult your doctor if you experience any severe or persistent symptoms.Q: How do I properly store Soranib 200 Mg Tablet at home?
A: Store the tablets in their original bottle below 30C, protected from moisture and light, and always keep them out of reach of children.Q: What is the recommended dosage and who is suitable to take Soranib?
A: The usual dosage is 200 mg per tablet, with the specific regimen determined by your oncologist. Soranib is suitable for adults diagnosed with advanced kidney, liver, or thyroid cancer.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
